Patients with heart failure (HF) and all animal models of HF exhibit an increased sympathetic neural activation, which increases the risk of morbidity and mortality. Standard therapy is to attempt to contain this sympatho- excitation in the face of reduced cardiac output. We have previously observed that neuronal activation within the paraventricular nucleus (PVN) of the hypothalamus may contribute to this elevated neuro-humoral drive. The mechanisms and source of this activation remain to be clearly delineated. Recently we uncovered enhanced excitatory mechanism mediated by 1) an intra-PVN hypoxia-induceable factor (HIF1-?); HIF1-? protein expression and immunostaining are increased in the PVN of rats with HF. A HIF1-? shRNA administered to the PVN normalized the increased renal sympathetic nerve activity (RSNA) in rats with HF. 2) A renal nerve dependent mechanism: Renal denervation (RDN) is a potentially new effective therapy for reducing sympathetic outflow in patients with hypertension. Our preliminary data shows that RDN reduces norepinephrine (NE) excretion in rats with HF, but not in sham rats, suggesting that RDN reduces sympatho- excitation in HF. Finally, as a therapeutic modality we have shown that exercise training (ExT) restores nNOS in the PVN and decreases neurohumoral activation in HF. This proposal tests the hypothesis that activation of HIF1-? and/or ascending information from the renal nerves contributes to the increased sympathetic drive in HF. Furthermore, ExT, may normalizes levels of HIF1-? and/or renal afferent input to the PVN in HF We propose to determine the underlying mechanisms for the activation of HIF1-? and/or ascending information from the renal nerves at the level of the PVN and subsequent sympatho-excitation in rats with HF. This goal will be accomplished by utilizing a multidisciplinary approach, ranging from studies in intact whole animals to studies in brain nuclei to individual neurons. We will use a variety of complementary techniques involving neuroanatomical, immunohistochemical, electrophysiological, molecular, cellular, and Adeno/Lenti viral gene transfer technology. The results will provide significant new information regarding central mechanisms of sympatho-excitation, specifically involvement of HIF1-? and/or ascending information from the renal nerves to the PVN in the increased sympathetic neural activation in the HF state. Understanding the role of these central mechanisms, not studied to date, in the increased sympathetic neural drive will enhance our ability to treat the HF condition and its cardiovascular complications.
A hallmark of chronic heart failure (HF) is increased sympathetic drive. This abnormality increases the risk of morbidity and mortality during HF. While there has been some progress in elucidating the peripheral mechanisms involved in these abnormalities, the mechanisms thus far identified do not totally account for the elevated neuro-humoral drive during HF. Understanding the role of central mechanisms and the therapeutic value of RDN and exercise training will enhance our ability to treat the HF condition and its systemic complications. To date there is growing evidence that exercise training is beneficial however the central mechanisms involved remain to be elucidated.
|Tian, Changhai; Gao, Lie; Zimmerman, Matthew C et al. (2018) Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure. Am J Physiol Heart Circ Physiol 314:H928-H939|
|Marcus, Noah J; Del Rio, Rodrigo; Ding, Yanfeng et al. (2018) KLF2 mediates enhanced chemoreflex sensitivity, disordered breathing and autonomic dysregulation in heart failure. J Physiol 596:3171-3185|
|Fontes, Marco Antônio Peliky; Vaz, Gisele Cristiane; Cardoso, Thais Zielke Dias et al. (2018) GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases. Nanomedicine 14:781-788|
|de Morais, Sharon D B; Shanks, Julia; Zucker, Irving H (2018) Integrative Physiological Aspects of Brain RAS in Hypertension. Curr Hypertens Rep 20:10|
|Zheng, Hong; Katsurada, Kenichi; Liu, Xuefei et al. (2018) Specific Afferent Renal Denervation Prevents Reduction in Neuronal Nitric Oxide Synthase Within the Paraventricular Nucleus in Rats With Chronic Heart Failure. Hypertension 72:667-675|
|Lewis, Robert; Hackfort, Bryan T; Schultz, Harold D (2018) Chronic Heart Failure Abolishes Circadian Rhythms in Resting and Chemoreflex Breathing. Adv Exp Med Biol 1071:129-136|
|Becker, Bryan K; Wang, Hanjun; Zucker, Irving H (2017) Central TrkB blockade attenuates ICV angiotensin II-hypertension and sympathetic nerve activity in male Sprague-Dawley rats. Auton Neurosci 205:77-86|
|Zheng, Hong; Liu, Xuefei; Li, Yulong et al. (2017) A Hypothalamic Leptin-Glutamate Interaction in the Regulation of Sympathetic Nerve Activity. Neural Plast 2017:2361675|
|Sharma, Neeru M; Nandi, Shyam S; Zheng, Hong et al. (2017) A novel role for miR-133a in centrally mediated activation of the renin-angiotensin system in congestive heart failure. Am J Physiol Heart Circ Physiol 312:H968-H979|
|Mishra, Paras K; Ying, Wei; Nandi, Shyam Sundar et al. (2017) Diabetic Cardiomyopathy: An Immunometabolic Perspective. Front Endocrinol (Lausanne) 8:72|
Showing the most recent 10 out of 169 publications